Reflux esophagitis Phase III study (Maintenance treatment)

Study identifier:D961HC00006

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A multicentre, randomised, double-blind, parallel-group, comparative study to compare the efficacy and safety of esomeprazole 20 mg once daily oral administration with omeprazole 10 mg and esomeprazole 10 mg once daily oral administration in maintenance treatment in patients with healed reflux esophagitis

Medical condition

reflux esophagitis

Phase

Phase 3

Healthy volunteers

No

Study drug

Esomeprazole, Omeprazole

Sex

All

Actual Enrollment

540

Study type

Interventional

Age

20 Years +

Date

Study Start Date: 01 Jan 2008
Primary Completion Date: -
Study Completion Date: 01 May 2009

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 May 2010 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria